Gov. Josh Shapiro, in his first 100 days in Pennsylvania's top job, visited the PABC on April 27 with Rick Siger, acting secretary of the Department of Community and Economic Development. Five days later he shared on social media a positive review of our operation. Please watch it here. His office's news release is here.
PABC launches a new podcast, "Biotech Insiders with Lou Kassa" <<listen here>>
Brandywine Realty Trust (NYSE: BDN) and Pennsylvania Biotechnology Center (PABC) announce B+labs at Cira Centre is not only open but fully leased. The list of life science leaders occupying the B+labs community includes 3D Systems, Asklepios Biopharmaceutical (AskBio), BriaCell Therapeutics Corp., Carisma Therapeutics, Ceptur Therapeutics, Quanta Therapeutics, Synapticure, Tmunity Therapeutics, Vetigenics, and Vitara Biomedical, among others. Please read more here.
Louis P. Kassa III, MPA, chief executive officer of the Hepatitis B Foundation, Baruch S. Blumberg Institute and Pennsylvania Biotechnology Center (PABC) was chosen by the Philadelphia Business Journal for its Power 101 list, which is being released this week. Kassa became named CEO of the organizations on July 1, succeeding co-founder Timothy M. Block, PhD. In 2019, Dr. Block was named by the Philadelphia Business Journal to its Power 100 list. Please read more here.
Learn More